Sandra Lucia Euzebio Ribeiro
Overview
Explore the profile of Sandra Lucia Euzebio Ribeiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sartori N, Machado K, Miyamoto S, Pretti F, Gouveia M, de Oliveira Y, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006674
Objective: To evaluate the humoral response to and impact of SARS-CoV-2 vaccination in patients with systemic lupus erythematosus in a multicenter cohort design. Methods: Data for this analysis were obtained...
2.
de Oliveira F, Appenzeller S, Pasoto S, Fernandes M, Lemos Lopes M, de Magalhaes Souza Fialho S, et al.
Adv Rheumatol
. 2025 Feb;
65(1):7.
PMID: 39934881
Background: Neurological and psychiatric manifestations occur in patients with primary Sjogren's disease (SjD) with a wide-ranging clinical presentation, affecting quality of life, social participation, and prognosis. Despite this, neither central...
3.
Marques C, Pinheiro M, Lopes J, Ribeiro S, de Castro M, de Azevedo Valadares L, et al.
Adv Rheumatol
. 2025 Jan;
65(1):4.
PMID: 39844312
Objectives: To compare the impact of COVID-19 on the clinical status and psychological distress of patients with immune-mediated rheumatic disease (IMRD) caused by SARS-CoV-2 infection with that of noninfected IMRD...
4.
Machado K, Burian A, Martins-Filho O, Mill J, Ferreira L, Tapia K, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772029
Background/objectives: The effectiveness of COVID-19 vaccine in patients with immune-mediated inflammatory diseases (IMID) depends on the underlying disease, immunosuppression degree and the vaccine regimens. We evaluate the safety and immunogenicity...
5.
Calderaro D, Valim V, Ferreira G, Machado K, Ribeiro P, Ribeiro S, et al.
Vaccines (Basel)
. 2024 Sep;
12(9).
PMID: 39340061
Breakthrough COVID-19 (occurring in fully vaccinated people) has been described. Data on its characteristics among immune-mediated rheumatic disease (IMRD) patients are scarce. This study describes breakthrough COVID-19 occurring in IMRD...
6.
Cruz V, Guimaraes C, Rego J, Machado K, Miyamoto S, Burian A, et al.
Adv Rheumatol
. 2024 Aug;
64(1):58.
PMID: 39135131
Background: Patients with immune-mediated rheumatic diseases (IMRDs) have been prioritized for COVID-19 vaccination to mitigate the infection severity risks. Patients with rheumatoid arthritis (RA) are at a high risk of...
7.
Pugliesi A, do Egypto D, Duffles G, Cantali D, Pasoto S, Oliveira F, et al.
Adv Rheumatol
. 2024 Jul;
64(1):51.
PMID: 38982553
Sjogren's disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and...
8.
Resende G, Saad C, Lopes Marques C, Ribeiro S, de Oliveira Gavi M, Yazbek M, et al.
Adv Rheumatol
. 2024 Apr;
64(1):33.
PMID: 38671475
Background: There is a remarkable variability in the frequency of HLA-B27 positivity in patients with spondyloarthritis (SpA), which may be associated with different clinical presentations worldwide. However, there is a...
9.
Isnardi C, Alpizar-Rodriguez D, Calderaro D, Lopes Marques C, Pons-Estel G, Xavier R, et al.
J Clin Rheumatol
. 2023 Nov;
30(1):e9-e17.
PMID: 37936271
Objective: To describe characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with rheumatic immune-mediated inflammatory diseases (IMIDs) from Argentina, Mexico and Brazil, and to assess factors...
10.
Cruz V, de Albuquerque C, Guimaraes M, Dionello C, Ribeiro S, de Souza V, et al.
Front Med (Lausanne)
. 2023 Oct;
10:1239775.
PMID: 37822467
Leprosy is an infectious and contagious disease of slow evolution, triggered by . Arthritis is its third most common manifestation, after cutaneous and peripheral nerve involvement. Since musculoskeletal symptoms may...